BCL2 and esophageal squamous cell carcinoma: Metformin induced esophageal squamous cell carcinoma (ESCC) cell autophagy and cell death via inhibiting the STAT3-B-cell lymphoma 2 (BCL2) pathway [181] and inhibited migration and invasion of ESCC cells by affecting NFκB nuclear localization [182].